News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GORDON CARL L
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Disposed/sold 30,000 options to buy
@ $16.11, valued at
$483.3k
Granted 30,000 options to buy
@ $0
Disposed/sold 18,500 options to buy
@ $15.93, valued at
$294.7k
Granted 18,500 options to buy
@ $0
Disposed/sold 18,500 options to buy
@ $11.49, valued at
$212.6k
Disposed/sold 26,400 options to buy
@ $5.195, valued at
$137.1k
Granted 26,400 options to buy
@ $0 |
|
| 07/19/2023 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 328,482 shares
@ $3.05, valued at
$1M
Bought 151,450 shares
@ $3.05, valued at
$461.9k
|
|
| 06/29/2023 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Bought 125,000 shares
@ $2.09, valued at
$261.3k
Bought 250,000 shares
@ $2.09, valued at
$522.5k
Bought 442,000 shares
@ $2.09, valued at
$923.8k
Bought 58,000 shares
@ $2.09, valued at
$121.2k
|
|
| 06/08/2023 |
4
| GORDON CARL L (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 06/02/2023 |
4
| GORDON CARL L (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 5,900 shares
@ $0
Granted 26,400 options to buy
@ $5.195, valued at
$137.1k
|
|
| 05/08/2023 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Bought 83,459 shares
@ $2.75, valued at
$229.5k
Bought 312,991 shares
@ $2.75, valued at
$860.7k
Bought 83,459 shares
@ $2.75, valued at
$229.5k
Bought 490,512 shares
@ $2.82, valued at
$1.4M
Bought 490,511 shares
@ $2.82, valued at
$1.4M
|
|
| 05/02/2023 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Bought 60,998 shares
@ $2.55, valued at
$155.5k
Bought 228,754 shares
@ $2.55, valued at
$583.3k
Bought 60,997 shares
@ $2.55, valued at
$155.5k
Bought 124,544 shares
@ $2.62, valued at
$326.3k
Bought 467,068 shares
@ $2.62, valued at
$1.2M
Bought 124,545 shares
@ $2.62, valued at
$326.3k
Bought 58,826 shares
@ $2.67, valued at
$157.1k
Bought 220,610 shares
@ $2.67, valued at
$589k
Bought 58,826 shares
@ $2.67, valued at
$157.1k
|
|
| 03/17/2023 |
4
| OrbiMed Israel BioFund GP Limited Partnership (10% Owner) has filed a Form 4 on BiomX Inc.|
Txns:
| Bought 348,000 shares
@ $0.245, valued at
$85.3k
Bought 1,789,959 warrants
@ $0.244, valued at
$436.7k
|
|
| 02/22/2023 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 550,000 shares
@ $0
Granted 550,000 shares
@ $0 |
|
| 02/09/2023 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Granted 60,000 options to buy
@ $3.93, valued at
$235.8k
|
|
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 402,000 shares
@ $3.21, valued at
$1.3M
|
|
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| GORDON CARL L (Director) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 20,250 options to buy
@ $8.38, valued at
$169.7k
|
|
| 06/13/2022 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $5.75, valued at
$172.5k
|
|
| 06/03/2022 |
4
| GORDON CARL L (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 18,500 options to buy
@ $11.49, valued at
$212.6k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| GORDON CARL L (Director) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Bought 156,000 shares
@ $10.22, valued at
$1.6M
Bought 20,700 shares
@ $9.98, valued at
$206.6k
Bought 10,000 shares
@ $9.89, valued at
$98.9k
Bought 9,000 shares
@ $9.96, valued at
$89.6k
|
|
| 01/21/2022 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 11,521 shares
@ $9.97, valued at
$114.9k
Bought 35,000 shares
@ $9.95, valued at
$348.3k
Bought 111,896 shares
@ $9.97, valued at
$1.1M
|
|
| 01/13/2022 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 1,600 shares
@ $9.81, valued at
$15.7k
Bought 6,900 shares
@ $10.67, valued at
$73.6k
Bought 18,897 shares
@ $10.06, valued at
$190.1k
Bought 17,320 shares
@ $9.43, valued at
$163.3k
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2021 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 1,785,715 shares
@ $3.5, valued at
$6.3M
Bought 3,571,428 shares
@ $3.5, valued at
$12.5M
|
|
| 10/14/2021 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Converted 15,777,018 shares
@ $0
Converted 436,650 shares
@ $0
Bought 562,500 shares
@ $16, valued at
$9M
Bought 62,500 shares
@ $16, valued at
$1M
Converted 14,903,718 convertible preferred
@ $0
Converted 873,300 convertible preferred
@ $0
Converted 436,650 convertible preferred
@ $0 |
|
| 10/08/2021 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 22,678 options to buy
@ $16, valued at
$362.8k
|
|
| 10/06/2021 |
3
| GORDON CARL L (10% Owner) has filed a Form 3 on Theseus Pharmaceuticals, Inc. |
| 10/06/2021 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Gemini Therapeutics, Inc. /DE|
Txns:
| Granted 17,245 options to buy
@ $3.8, valued at
$65.5k
|
|
| 06/17/2021 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Granted 16,625 options to buy
@ $19.03, valued at
$316.4k
|
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|